G蛋白Rab3a协同神经生长抑制因子(GIF)抑制神经元的生长

为了研究G蛋白Rab3a与神经生长抑制因子 (growthinhibitoryfactor,GIF ,原称金属硫蛋白 3,MT 3)相互作用对神经元细胞生长的影响 ,以嗜铬细胞瘤株 (pheochromocytoma)PC1 2充当神经元模型 .将hMT 3(humanMT 3)和Rab3a基因分别克隆至真核表达载体pFlag CMV 2和pSV HA中 ,质粒共同转染PC1 2细胞 ,观察转染后细胞的生长状态 .以共转染pFlag CMV 2 hMT 1和pSV HA Rab3a的细胞组作为对照 ,验证hMT 3与Rab3a相互作用对PC1 2影响的特异性 .结果发现 ,共转染pFlag CMV 2 hMT 3和pSV HA Rab3a的PC1 2细胞生长明显受到抑制 ,细胞生长抑制率与GIF在脑提取物存在F的神经元生长抑制作用接近 ,但转染两基因中的任何单个基因以及共转染pFlag CMV 2 hMT 1和pSV HA Rab3a对PC1 2细胞生长无影响 .进一步构建重组表达质粒pGEX 4T 1 Rab3a和pGEX 4T 1 hMT 3,转化大肠杆菌BL2 1 ,经谷胱甘肽 Sepharose 4B亲和层析、凝血酶酶切和SephacrylS 1 0 0纯化 ,得到纯度 95 %以上的Rab3a和hMT 3蛋白 .体外细胞生物学活性检测表明 ,表达的Rab3a蛋白与重组hMT 3蛋白共培养PC1 2 ,对细胞的生长产生了明显的特异性协同抑制作用 ,抑制曲线与GIF在脑提取物存在下的神经元生长抑制曲线极为相似     

G-蛋白 Rab3a 对神经生长抑制因子 (GIF) 抑制神经元细胞生长作用的影响

为了深入研究 Rab3a 和神经生长抑制因子 (GIF) 的相互作用,在大鼠海马神经元细胞原代培养体系中,用 MTT 还原法定量研究了 Rab3a 对 GIF 神经生长活性的影响,发现 Rab3a 可以替代脑提取物而使 GIF 发挥神经生长抑制活性 . 接着又利用多克隆抗体方法研究了 GIF 与 Rab3a 的相互作用,结果说明 Rab3a 是 GIF 发挥神经生长抑制活性所必需的蛋白质,并且它们的相互作用受空间位置的因素影响较大 . 在随后对它们相互作用的机理和可能的生物学意义进行了讨论 .     

神经生长抑制因子相互作用蛋白的分子克隆、鉴定及其生物学特性

为了探讨神经生长抑制因子(Neuronal growth inhibitory factor,GIF)与Alzheimer’s病(Alzheimer’s disease,AD)的关系,将GIF的cDNA全基因克隆到载体pHyblex中,运用酵母双杂交系统从Alzheimer’s病人脑cDNA文库中筛选出与GIF相互作用蛋白的cDNA克隆。免疫共沉淀和蛋白质印迹实验进一步验证了该蛋白在体内与GIF相互作用的特异性。克隆并鉴定了其中1个与GIF特异性结合的蛋白,与人细胞核dUTP焦磷酸酶(DUT)同源。进一步构建了重组表达质粒pGEX-4T-1／DUT,转化大肠杆菌BL21,经谷胱甘肽-Sepharose 4B亲和层析、凝血酶酶切和Sephacryl S100纯化,得到纯度95％以上的dUTPase蛋白。体外生物学活性检测表明,表达的dUTPase蛋白可以与GIF共同作用嗜铬细胞瘤株(pheochromocytoma)PC12,对细胞的生长产生抑制作用。     

G蛋白Rab3a cDNA的克隆与表达

利用PCR法 ,从人胎盘总cDNA中扩增得到Rab3acDNA的全编码区 .序列分析表明 ,扩增得到的Rab3acDNA有 5个核苷酸发生了变异 ,但翻译的氨基酸与发表的完全一致 .将扩增得到的Rab3acDNA克隆于原核融合表达载体pGEX 4T 1中 ,在E .coliBL2 1中经IPTG诱导表达 .为了进一步鉴定表达产物 ,对纯化后的Rab3a蛋白进行了SDS PAGE、N端氨基酸测序、质谱分子量测定及氨基酸组成分析鉴定 .结果显示 ,表达蛋白的分子量约 2 5kD ,N端氨基酸序列为MASATDSR ,氨基酸组成分析表明 ,Rab3a蛋白获得了正确表达     

人mRNA输出因子Gle1与肽链释放因子相互作用上调HeLa细胞中蛋白质翻译终止活性

Gle1蛋白是一种mRNA核输出因子. 最近有研究报道Gle1蛋白参与了酿酒酵母的蛋白质翻译终止过程. 为了探讨Gle1蛋白是否在其它生物中也具有同样的功能, 本研究利用酵母双杂交、免疫共沉淀以及免疫共定位等方法证实了人Gle1蛋白与参与蛋白质合成终止的两类肽链释放因子均能够相互作用, 提示hGle1蛋白可能在人细胞中参与了蛋白质的翻译终止过程. 进一步在HeLa细胞中利用双荧光素酶报告系统分析人Gle1蛋白对蛋白质翻译终止的影响,结果显示, hGle1的过表达能促进细胞内蛋白质的翻译终止. 为进一步探讨hGle1蛋白在蛋白质合成中的作用机制奠定了基础.     

ADAM22蛋白与14-3-3β蛋白之间的相互作用

ADAM家族是一类具有去整合域和金属蛋白酶域的跨膜蛋白, 广泛参与各种重要的生理过程, 如精卵结合、神经系统发育、成肌细胞融合以及炎症反应等. 该家族蛋白具备潜在的粘连和蛋白酶活性. adam22在脑部高度表达, 基因剔除小鼠则出现严重的共济失调, 并在断奶前死亡, 但其作用机制不详. 用酵母双杂合系统筛选到与ADAM22相互作用的蛋白质14-3-3b, 离体结合实验、免疫共沉淀进一步证实了ADAM22与14-3-3β蛋白相互作用的专一性. ADAM22胞内部分系列缺失实验表明, C端第864~892氨基酸残基是14-3-3β的结合基序. 14-3-3β在脑部大量表达, 具有介导细胞的扩散、迁移及调节细胞周期等重要功能. 因此, 本实验证实这两种蛋白质之间存在相互作用,为阐明ADAM22在神经系统发育中的功能奠定了基础.     

PML-C与GINS2蛋白相互作用的胞内验证

目的 通过胞内实验验证PML-C与GINS2蛋白之间的相互作用.方法 将诱饵蛋白质粒pGBKT7-PML-C和文库蛋白质粒pACT2-GINS2共转化AH109酵母菌,通过一对一的酵母双杂交技术验证两者在活细胞内的相互作用;构建pCMV-HA-PML-C及pCMV-Myc-GINS2真核表达载体并共转染人胚肾293细胞,利用免疫共沉淀技术验证二者之间的相互作用.结果 pGBKT7-PML-C诱饵蛋白质粒和pACT2-GINS2靶蛋白质粒共转化AH109酵母菌后,可见蓝色阳性克隆生长;pCMV-HA-PML-C及pCMV-Myc-GINS2真核表达载体构建成功,共转染293细胞,抗HA多克隆抗体沉淀与HA-PML-C相互作用的蛋白复合物后,用抗Myc单克隆抗体进行Western印迹检测,可以检测到Myc-GINS2蛋白.结论 利用酵母双杂交和免疫共沉淀技术在胞内验证了PML-C与GINS2间存在相互作用.     

酵母双杂交筛选人乳腺cDNA文库中与Gankyrin相互作用的蛋白

目的：应用酵母双杂交技术,筛选与Gankyrin有相互作用的蛋白质。方法：应用酵母双杂交系统,以Gankyrin基因全长为诱饵,在人乳腺cDNA文库中筛选能与Gankyrin相互作用的蛋白质,并运用营养缺陷型培养基和X-α-Gal等实验提供的信息,筛除假阳性克隆。结果：以Gankyrin为诱饵筛选出了5个阳性克隆,对其中一个蛋白质RhoGDI2与Gankyrin进行了免疫共沉淀与GSTpull-down实验验证,证实了它们的相互作用。结论：Gankyrin能与RhoGDI2发生相互作用,在此基础上,可以开展Gankyrin调控肿瘤发生机制的研究。     

PML coiled-coil结构域与RAN结合蛋白9相互作用的验证

目的验证前髓细胞性白血病的卷曲螺旋结构域（PML—C）和RAN结合蛋白9（RANBP9）之间的相互作用。方法构建分别表达诱饵蛋白PML—C和靶蛋白RANBP9的载体pGBKT7-PML-C和pACT2-RANBP9,然后转人酵母AH109,培养3～5d后对其是否有胞内相互作用进行检测。将目的片断PML-C和RANBP9再次构建于真核生物表达载体pCMV—HA和pCMV—myc里,然后共转染人胚肾293细胞里（HEK293）,最后对其是否有体外相互作用通过免疫共沉淀和免疫印迹进行分析。结果在共转化了质粒pGBKT7-PML—C和pACT2-RANBP9的AH109酵母平板里观察到蓝色菌落生长。用抗HA多克隆抗体对共转染过重组质粒的HEK293细胞的蛋白提取物进行免疫共沉淀,再用抗myc单克隆抗体作为一抗进行免疫印迹,最终检测出融合蛋白myc—RANBP9条带。结论酵母双杂交实验验证了PML—C和RANBP9之间存在胞内相互作用,同时免疫共沉淀实验也从体外验证了它们之间的相互作用。     

GGN3与GGNBP2的相互作用及作用区域确定

生殖细胞缺陷症(gcd)小鼠突变体是上世纪90年代初发现的一种不育突变小鼠,FancL(也叫Pog)的缺失是产生god突变小鼠的原因。FANCL是一种含有PHD结构域的泛素E3连接酶,是Fanconi贫血复合物中的组分之一。在生殖细胞中,FANCL与GGN1和GGN3相互作用,而GGN1和GGN3蛋白的功能还不清楚。为了研究GGN3的功能,揭示更多的参与该过程的蛋白质,运用Clontech公司新开发的第三套酵母双杂交系统以GGN3为诱饵从成年小鼠睾丸cDNA库中筛选与其相互作用的蛋白分子。发现了一个精子生成期间在睾丸中特异性高表达的基因Ggnbp2,免疫共沉淀分析表明,Ggnbp2编码的蛋白质产物GGNBP2在哺乳动物细胞中与GGN3特异相互作用。通过构建突变体,确定了GGNBP2蛋白与GGN3相互作用的区域。以上结果为揭示GGN3和GGNBP2在生殖发育中的功能、丰富生殖细胞发育的蛋白调控网络及其调控规律奠定了一定的基础。     

神经生长抑制因子研究进展

神经生长抑制因子(neuronal growth inhibitory factor, GIF) 又名金属硫蛋白-Ⅲ (metallothionein-Ⅲ,MT-Ⅲ),特异分布于中枢神经系统(CNS),是神经系统中第一个被鉴定的具有神经元生长抑制功能的蛋白. GIF一级序列、高级结构、金属结合特性类似于其他MTs,基因结构也与其他MTs高度同源,但表达调控途径相异. GIF可能以其β结构域的CPCP区,与脑组织提取物中的相关因子结合,进而表现其生物学功能. 有研究认为GIF与阿尔茨海默等脑相关疾病均有密切关系.     

Schwannoma-Derived Growth Factor Interacts with the Epidermal Growth Factor Receptor

Abstract: Schwannoma-derived growth factor (SDGF) is a potent mitogen and neuronal differentiation factor. Because of its relationship to epidermal growth factor (EGF) and the heregulins, it was asked if SDGF interacts with the EGF receptor or HER2/neu. SDGF binds to and causes the phosphorylation on tyrosine of the EGF receptor but not HER2/neu.     

Molecular and functional interactions of alpha-synuclein with Rab3a

Alpha-synuclein (a-Syn) is a presynaptic protein, the misfolding of which is associated with Parkinson’s disease. Rab GTPases are small guanine nucleotide binding proteins that play key roles in vesicle trafficking and have been associated with a-Syn function and dysfunction. a-Syn is enriched on synaptic vesicles, where it has been reported to interact with GTP-bound Rab3a, a master regulator of synaptic vesicle trafficking. a-Syn is known to bind weakly to Rab8a in solution via a positively charged patch, but the physiological implications of such interactions have not been explored. Here, we investigate direct interactions between a-Syn and Rab3a in solution and on lipid membranes using NMR spectroscopy. We find that the C terminus of a-Syn interacts with Rab3a in a manner similar to its previously reported interaction with Rab8a. While weak in solution, we demonstrate that this interaction becomes stronger when the proteins are bound to a membrane surface. The Rab3a binding site for a-Syn is similar to the surface that contacts the Rab3a effector rabphilin-3A, which modulates the enzymatic activity of Rab3a. Accordingly, we show that a-Syn inhibits GTP hydrolysis by Rab3a and that inhibition is more potent on the membrane surface, suggesting that their interaction may be functionally relevant. Finally, we show that phosphorylation of a-Syn residue Ser 129, a modification associated with Parkinson’s disease pathology, enhances its interactions with Rab3a and increases its ability to inhibit Rab3a GTP hydrolysis. These results represent the first observation of a functional role for synuclein-Rab interactions and for a-Syn Ser 129 phosphorylation.     

利用酵母双杂交系统研究人血管内皮生长因子受体Flt-1的配体结合域

The vascular endothelial growth factor (VEGF) receptor Flt-1 is charaterized by seven Ig-like loops within the extracellular domain. To identify which part is responsible for ligand binding, four cDNA clones coding for truncated Flt-1 mutants consisting of loop 1, 1-2, 2-3 and 1-3 were obtained by PCR from human cardiac cDNA library and inserted into the vectors of the yeast two-hybrid system, with VEGF cDNA on the partner plasmid. The paired plasmids were transformed into yeast strain SFY526, and tested by filter membrane method and β-galactosidase activity. The results showed that Flt-1(1-2)、Flt-1(2-3) and Flt-1(1-3) all were able to bind VEGF, of which Flt-1(1-3) showed the highest binding affinity, but no binding of VEGF was observed with Flt-1(2) and VEGF.     

Physicochemical Characterization of Recombinant Human Nerve Growth Factor Produced in Insect Cells with a Baculovirus Vector

Recombinant human nerve growth factor (rhNGF) secreted by insect cells was purified by ion-exchange and reversed-phase chromatography to near homogeneity. The N-terminus of the secreted molecule was analogous to that of mouse salivary gland NGF. In its native conformation, the insect cell produced rhNGF molecules were homodimers consisting of 120 amino acid polypeptide chains. Mature rhNGF was found not to be significantly glycosylated (less than 0.08 mol of N-acetylglucosamine/mol of protein). The rhNGF was homogeneous with regard to molecular weight and amino acid sequence. Isoelectric focusing resolved the rhNGF into one major and one minor component. Because rhNGF from insect cells can be obtained in large quantities, purified to near homogeneity, and is similar to natural NGF with regard to physicochemical properties and biological activity, it is suitable for further evaluation in animal models as a therapeutic molecule for neurodegenerative diseases such as Alzheimer's disease.     

Importance of the Rab3a-GTP Binding Domain for the Intracellular Stability and Function of Rabphilin3a in Secretion

Abstract: We had previously demonstrated that Rab3a-GTP inhibits and the Rab3a-binding protein Rabphilin3a enhances secretion in bovine chromaffin cells. In this study, we investigated the role of Rab3a-GTP binding in the intracellular expression and the function of Rabphilin3a in regulated exocytosis in bovine chromaffin cells. Using transient transfections, we found that a minimal domain, Rp(51–190), that inhibits secretion coincides with a minimal domain that effectively binds Rab3a-GTP and allows intracellular stability of the construct. This domain includes a cysteine-rich, Zn²⁺-binding domain whose integrity is also required for Rab3a-GTP binding and the ability to inhibit secretion. A Rabphilin3a mutant, containing both C2 domains but defective in Rab3a-GTP, and wild-type Rabphilin3a both localized to chromaffin granules and stimulated secretion similarly despite lessened intracellular expression of the mutant protein. The data are consistent with a sequence of events in which a Rab3a-GTP · Rabphilin3a complex forms on the secretory granule as a precursor in a pathway that enhances secretion. The complex dissociates (perhaps because of GTP hydrolysis) to permit the enhancement of secretion by Rabphilin3a.     

Insulin-Like Growth Factor I Receptor Binding in Brains of Alzheimer''s and Alcoholic Patients

Patients with chronic alcoholism and/or Alzheimer's disease show degenerative changes in the cerebral cortex and hippocampus. To investigate possible changes in insulin-like growth factor I receptor binding sites in brain tissue of patients with these pathological conditions, the number of 125I-insulin-like growth factor I binding sites was determined in tissues obtained from control patients and those with Alzheimer's and/or with a history of alcoholism. The four experimental groups examined consisted of patients from similar age groups. Postmortem histology and a clinical history were used for the diagnosis of Alzheimer's disease and alcoholism, respectively. Careful clinical records were kept concerning other variables such as immediate cause of death and medications administered before death. Specific binding of 125I-insulin-like growth factor I to homogenates prepared from cerebral cortex of Alzheimer's, alcoholic, alcoholic Alzheimer's, and age-matched control patients was similar, although Alzheimer's patients tended to have slightly higher binding values. No significant differences in insulin-like growth factor I binding in cerebral cortex were found with regard to age of patients, the interval between death and autopsy, and CNS-active medications. No statistical differences in 125I-insulin-like growth factor I binding were noted in hippocampal tissue from the four patient groups. Thus, human insulin-like growth factor I binding sites in cerebral cortex and hippocampus appear unaffected by several variables.